Early fusion intermediate of ACE2-using coronavirus spike acting as an antiviral target
Lixiao Xing, Zhimin Liu, Xinling Wang, Qianying Liu, Wei Xu, Qiyu Mao, Xiang Zhang, Aihua Hao, Shuai Xia, Zezhong Liu, Lujia Sun, Guangxu Zhang, Qian Wang, Zhenguo Chen, Shibo Jiang, Lei Sun, Lu Lu, Lei Sun, Lu Lu
Topics & Concepts
BiologyCoronavirusSpike (software development)VirologyCoronavirus disease 2019 (COVID-19)Spike Protein2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Lipid bilayer fusionBetacoronavirusComputational biologyVirusOutbreakInfectious disease (medical specialty)ManagementEconomicsMedicinePathologyDiseaseSARS-CoV-2 and COVID-19 ResearchViral gastroenteritis research and epidemiologyViral Infections and Immunology Research